Related Experiment Video
Updated: Mar 21, 2026

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
Published on: February 3, 2023
Biliary atresia and other cholestatic childhood diseases: Advances and future challenges
Henkjan J Verkade1, Jorge A Bezerra2, Mark Davenport3
1Department of Paediatrics, University of Groningen, Beatrix Children's Hospital/University Medical Center, Groningen, The Netherlands.
Insights
Biliary atresia (BA) and rare childhood cholestatic liver diseases are uncommon but lead to liver transplants in children. This review highlights research advances, challenges, and future priorities for these conditions.
Area of Science:
- Pediatric Hepatology
- Rare Childhood Diseases
- Gastroenterology
Background:
- Biliary atresia (BA) and other cholestatic childhood diseases present with neonatal cholestatic jaundice.
- These rare conditions affect the bile duct system, with BA being the most common.
- Genetic disorders like Alagille syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC) are less frequent.
Purpose of the Study:
- To review recent advances in basic research and clinical progress for BA and related cholestatic childhood diseases.
- To identify current key questions, controversies, and research needs in the field.
- To establish top priorities for future research to improve understanding and treatment.
Main Methods:
- Literature review of recent advances in basic research.
- Analysis of clinical progress and outcomes.
- Formulation of key research questions and priorities based on current knowledge gaps.
Main Results:
- Despite individual rarity, these diseases are leading indications for pediatric liver transplantation.
- Low incidence hinders large patient-based studies and the development of effective animal models.
- Recent progress in understanding disease mechanisms and clinical management has been made.
Conclusions:
- Future research should focus on addressing key questions and controversies identified.
- Developing better animal models and facilitating larger patient-based studies are crucial.
- Prioritizing research efforts will accelerate the development of novel treatments for these rare conditions.
Abstract:
Biliary Atresia and other cholestatic childhood diseases are rare conditions affecting the function and/or anatomy along the canalicular-bile duct continuum, characterised by onset of persistent cholestatic jaundice during the neonatal period. Biliary atresia (BA) is the most common among these, but still has an incidence of only 1 in 10-19,000 in Europe and North America. Other diseases such as the genetic conditions, Alagille syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC), are less common. Choledochal malformations are amenable to surgical correction and require a high index of suspicion. The low incidence of such diseases hinder patient-based studies that include large cohorts, while the limited numbers of animal models of disease that recapitulate the spectrum of disease phenotypes hinders both basic research and the development of new treatments. Despite their individual rarity, collectively BA and other cholestatic childhood diseases are the commonest indications for liver transplantation during childhood. Here, we review the recent advances in basic research and clinical progress in these diseases, as well as the research needs. For the various diseases, we formulate current key questions and controversies and identify top priorities to guide future research.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
